The Impact of Vitamin D Supplementation on Pregnant Women With the Risk of GDM
Status:
Not yet recruiting
Trial end date:
2025-12-01
Target enrollment:
Participant gender:
Summary
A clinical trial will be conducted in Chemical pathology department in collaboration with
Gyne &Obs department of PRH, IIMC over a period of 02 years w.e.f. December 15, 2023. 350
pregnant women with 07-11 weeks of gestation and having a high risk for GDM with low Vitamin
D3 levels and normal response to 75g OGTT will be randomly assigned to receive either vitamin
D3 supplementation (2 00,000 IU/Week) for 04 -06 weeks or Placebo. These women will be
checked for the diagnosis of GDM with 75 g OGTT at 24- 28 weeks of gestation. The outcome of
the study will be the incidence of GDM based on the International Association of Diabetes and
Pregnancy Study Groups Criteria.